SURMOUNT-1: Tirzepatide results in 22.5% weight loss in adults with obesity or overweightTirzepatide (5 mg, 10 mg, 15 mg) achieved superior weight loss compared to placebo at 72 weeks of treatment in topline results from Eli...
Standardisation of OAGB is key to reducing surgical errors and ensuring consistent patient outcomes1 day ago